Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lack of macrolide resistance in Chlamydia trachomatis after mass azithromycin distributions for trachoma.

Emerging infectious diseases - 1 Jul 2009

Hong Kevin Cyrus, Schachter Julius, Moncada Jeanne, Zhou Zhaoxia, House Jenafir, Lietman Thomas M

Abstract excerpt

We investigated antimicrobial drug resistance in ocular Chlamydia trachomatis 18 months after 4 biannual communitywide distributions of antimicrobial drugs in a region of Ethiopia where ocular strains of C. trachomatis are highly endemic. We found no significant differences in susceptibilities to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Topical
Share to Azithromycin
Share to Chlamydia trachomatis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cycloheximide

Share to Drug Resistance, Microbial

Share to Ethiopia

Share to Eye Diseases

Share to Pregnancy Complications, Infectious

Source

Open in PubMed Open full text

Identifiers

PMID: 19624926
DOI: 10.3201/eid1507.081563
PMCID: PMC2744222

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19624926-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lack of macrolide resistance in Chlamydia trachomatis after mass azithromycin distributions for trachoma.PMID 19624926Read ↗

Genomics of Ocular Chlamydia trachomatis After 5 Years of SAFE Interventions for Trachoma in Amhara, EthiopiaSemantic proximity Read ↗

Diversity of Chlamydia trachomatis in Trachoma-Hyperendemic Communities Treated With Azithromycin.Semantic proximity Read ↗

Clinical Activity and Polymerase Chain Reaction Evidence of Chlamydial Infection after Repeated Mass Antibiotic Treatments for TrachomaSemantic proximity Read ↗

Evidence for Clonal Expansion After Antibiotic Selection Pressure: Pneumococcal Multilocus Sequence Types Before and After Mass Azithromycin TreatmentsSemantic proximity Read ↗

High treatment failure rate is better explained by resistance gene detection than by minimum inhibitory concentration in patients with urogenital Chlamydia trachomatis infectionSemantic proximity Read ↗

Genomics of Ocular <i>Chlamydia trachomatis</i> after 5 years of SAFE interventions for trachoma in Amhara, EthiopiaSemantic proximity Read ↗

Macrolide and fluoroquinolone resistance is uncommon in clinical strains of Chlamydia trachomatisSemantic proximity Read ↗

Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infections.Semantic proximity Read ↗

Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.Semantic proximity Read ↗

Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycinSemantic proximity Read ↗

Molecular mechanisms of Chlamydia trachomatis resistance to antimicrobial drugs.Semantic proximity Read ↗

Direct assessment of possible mutations in the 23S rRNA gene encoding macrolide resistance in Chlamydia trachomatis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.